Pronađeno: 1-5 / 5 radova

Autori: Compston Alastair

>> Filter: Samo Article i Review

>> Sve godine

Naslov Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study (Meeting Abstract)
Autori Arnold Douglas L Brinar Vesna Cohen Jeffrey Coles Alasdair Confavreux Christian Fisher Elizabeth Fox Edward Giovannoni Gavin Hartung Hans Havrdova Eva Selmaj Krzysztof Weiner Howard Stojanovic Miroslav Lake Stephen Margolin David Panzara Michael Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I) (Meeting Abstract)
Autori Havrdova Eva Arnold Douglas L Cohen Jeffrey Coles Alasdair Confavreux Christian Fox Edward Hartung Hans Selmaj Krzysztof Weiner Howard Brinar Vesna Giovannoni Gavin Stojanovic Miroslav Lake Stephen Margolin David Oyuela Pedro Panzara Michael Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Incidence of Autoimmunity in a Phase 3 Trial: Comparison of Alemtuzumab and Rebif (R) in Multiple Sclerosis I (CARE-MS I) (Meeting Abstract)
Autori Selmaj Krzysztof Arnold Douglas L Brinar Vesna Cohen Jeffrey Coles Alasdair Confavreux Christian Fox Edward Giovannoni Gavin Hartung Hans Havrdova Eva Stojanovic Miroslav Weiner Howard Lake Stephen Margolin David Oyuela Pedro Panzara Michael Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints (Meeting Abstract)
Autori Fox Edward Arnold Douglas L Brinar Vesna Cohen Jeffrey Coles Alasdair Confavreux Christian Giovannoni Gavin Hartung Hans Havrdova Eva Selmaj Krzysztof Stojanovic Miroslav Weiner Howard Lake Stephen Margolin David Panzara Michael Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients (Meeting Abstract)
Autori Coles Alasdair Brinar Vesna Arnold Douglas L Cohen Jeffrey Confavreux Christian Fox Edward Hartung Hans Havrdova Eva Selmaj Krzysztof Weiner Howard Giovannoni Gavin Stojanovic Miroslav Lake Stephen Margolin David Panzara Michael Compston Alastair 
Info NEUROLOGY, (2012), vol. 78 br. , Suppl. 1, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX